Page 109 - Read Online

Yang et al. Mini-invasive Surg 2021;5:11 I http://dx.doi.org/10.20517/2574-1225.2021.06 Page 11 of 12

2. Morton JM. Ethnic Considerations for Metabolic Surgery. Diabetes Care 2016;39:949-53.
3. International Diabetes Federation [Internet]. IDF diabetes atlas 8th edition; 2017 Available from: https://www.idf.org/e-library/
epidemiology-research/diabetes-atlas/134-idf-diabetes-atlas-8th-edition.html [Last accessed on 26 Feb 2021]
4. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. The Lancet 2004;363:157-
63.
5. Du X, Dai R, Zhou HX, et al. Bariatric Surgery in China: How Is This New Concept Going? Obes Surg 2016;26:2906-12.
6. O’Neill S, O’Driscoll L. Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies. Obes Rev 2015;16:1-
12.
7. Ruan Y, Mo M, Joss-Moore L, et al. Increased waist circumference and prevalence of type 2 diabetes and hypertension in Chinese adults:
two population-based cross-sectional surveys in Shanghai, China. BMJ Open 2013;3:e003408.
8. Gujral UP, Pradeepa R, Weber MB, Narayan KM, Mohan V. Type 2 diabetes in South Asians: similarities and differences with white
Caucasian and other populations. Ann N Y Acad Sci 2013;1281:51-63.
9. Hou X, Lu J, Weng J, et al; China National Diabetes and Metabolic Disorders Study Group. Impact of waist circumference and body
mass index on risk of cardiometabolic disorder and cardiovascular disease in Chinese adults: a national diabetes and metabolic disorders
survey. PLoS One 2013;8:e57319.
10. Hales CM, Fryar CD, Carroll MD, Freedman DS, Ogden CL. Trends in Obesity and Severe Obesity Prevalence in US Youth and Adults
by Sex and Age, 2007-2008 to 2015-2016. JAMA 2018;319:1723-5.
11. Schauer PR, Mingrone G, Ikramuddin S, Wolfe B. Clinical Outcomes of Metabolic Surgery: Efficacy of Glycemic Control, Weight Loss,
and Remission of Diabetes. Diabetes Care 2016;39:902-11.
12. Wang G, Zhu L, Li W, Yang X, Li P, Zhu S. Can low BMI Chinese patients with type 2 diabetes benefit from laparoscopic Roux-en-Y
gastric bypass surgery? Surg Obes Relat Dis 2016;12:1890-5.
13. Liang H, Guan W, Yang Y, et al. Roux-en-Y gastric bypass for Chinese type 2 diabetes mellitus patients with a BMI < 28 kg/m(2): a
multi-institutional study. J Biomed Res 2015;29:112-7.
14. Agha R, Abdall-Razak A, Crossley E, Dowlut N, Iosifidis C, Mathew G; STROCSS Group. STROCSS 2019 Guideline: Strengthening
the reporting of cohort studies in surgery. Int J Surg 2019;72:156-65.
15. Zhang P, Zhang H, Han X, et al. Effectiveness and safety of laparoscopic Roux-en-Y gastric bypass for the treatment of type 2 diabetes
mellitus. Exp Ther Med 2016;11:827-31.
16. Fuchs HF, Broderick RC, Harnsberger CR, et al. Benefits of bariatric surgery do not reach obese men. J Laparoendosc Adv Surg Tech A
2015;25:196-201.
17. Rubino F, Nathan DM, Eckel RH, et al; Delegates of the 2nd Diabetes Surgery Summit. Metabolic Surgery in the Treatment Algorithm
for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations. Surg Obes Relat Dis 2016;12:1144-62.
18. Sjöström L, Peltonen M, Jacobson P, et al. Association of bariatric surgery with long-term remission of type 2 diabetes and with
microvascular and macrovascular complications. JAMA 2014;311:2297-304.
19. Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J
Med 2009;122:248-256.e5.
20. Kalkan A, Bodegard J, Sundström J, et al. Increased healthcare utilization costs following initiation of insulin treatment in type 2 diabetes:
A long-term follow-up in clinical practice. Prim Care Diabetes 2017;11:184-92.
21. Park JY. Prediction of Type 2 Diabetes Remission after Bariatric or Metabolic Surgery. J Obes Metab Syndr 2018;27:213-22.
22. Hayes MT, Hunt LA, Foo J, Tychinskaya Y, Stubbs RS. A model for predicting the resolution of type 2 diabetes in severely obese subjects
following Roux-en Y gastric bypass surgery. Obes Surg 2011;21:910-6.
23. Hamza N, Abbas MH, Darwish A, Shafeek Z, New J, Ammori BJ. Predictors of remission of type 2 diabetes mellitus after laparoscopic
gastric banding and bypass. Surg Obes Relat Dis 2011;7:691-6.
24. Blackstone R, Bunt JC, Cortés MC, Sugerman HJ. Type 2 diabetes after gastric bypass: remission in five models using HbA1c, fasting
blood glucose, and medication status. Surg Obes Relat Dis 2012;8:548-55.
25. Aarts EO, Janssen J, Janssen IM, Berends FJ, Telting D, de Boer H. Preoperative fasting plasma C-peptide level may help to predict
diabetes outcome after gastric bypass surgery. Obes Surg 2013;23:867-73.
26. Schauer PR, Bhatt DL, Kirwan JP, et al; STAMPEDE Investigators. Bariatric surgery versus intensive medical therapy for diabetes-3-year
outcomes. N Engl J Med 2014;370:2002-13.
27. Bhasker AG, Remedios C, Batra P, Sood A, Shaikh S, Lakdawala M. Predictors of Remission of T2DM and Metabolic Effects after
Laparoscopic Roux-en-y Gastric Bypass in Obese Indian Diabetics-a 5-Year Study. Obes Surg 2015;25:1191-7.
28. Yu H, Di J, Bao Y, et al. Visceral fat area as a new predictor of short-term diabetes remission after Roux-en-Y gastric bypass surgery in
2
Chinese patients with a body mass index less than 35 kg/m . Surg Obes Relat Dis 2015;11:6-11.
29. Park JY, Kim YJ. Prediction of Diabetes Remission in Morbidly Obese Patients After Roux-en-Y Gastric Bypass. Obes Surg 2016;26:749-
56.
30. Scopinaro N, Adami GF, Bruzzi P, Cordera R. Prediction of Diabetes Remission at Long Term Following Biliopancreatic Diversion. Obes
Surg 2017;27:1705-8.
31. Still CD, Wood GC, Benotti P, et al. Preoperative prediction of type 2 diabetes remission after Roux-en-Y gastric bypass surgery: a
retrospective cohort study. Lancet Diabetes Endocrinol 2014;2:38-45.
32. Lee WJ, Hur KY, Lakadawala M, et al. Predicting success of metabolic surgery: age, body mass index, C-peptide, and duration score.
Surg Obes Relat Dis 2013;9:379-84.